Home › Glycogen Storage Disease › North Carolina
Glycogen Storage Disease clinical trials in North Carolina
3 studies for Glycogen Storage Disease are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- Duke University, Durham
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Jul 20, 2026 · NCT07282847Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
- Duke University Medical Center, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07123155Rare Glycogen Storage Diseases Natural History Study
- Duke University, Durham
RecruitingObservational study
Ages 0 to 90 · All sexes · Updated Jan 7, 2026 · NCT06795152From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.